Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Income and Comprehensive Income

v3.20.1
Condensed Consolidated Statements of Income and Comprehensive Income - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Condensed Consolidated Statements of Income and Comprehensive Income [Abstract]    
Sales $ 9,162,742 $ 11,216,170
Cost of sales 5,425,595 6,589,954
Gross profit 3,737,147 4,626,216
Operating expenses:    
Selling, general and administrative expenses 4,960,890 5,447,595
Total operating expenses 4,960,890 5,447,595
Operating loss from continuing operations (1,223,743) (821,379)
Other income (expenses):    
Investment and other income 111,757 44,890
Gain (loss) on sale of assets 308,403 (9,935)
Interest and other expense (9,593) (9,444)
Other income, net 410,567 25,511
Operating loss from continuing operations before income taxes (813,176) (795,868)
Income tax benefit (4,457) (3,972)
Net loss from continuing operations (808,719) (791,896)
Net income from discontinued operations, net of tax 2,313,352 1,032,009
Net income 1,504,633 240,113
Other comprehensive (loss) income, net of tax:    
Unrealized loss on available-for-sale securities (14,452)  
Foreign currency translation adjustment (132,103) 28,618
Total other comprehensive (loss) income (146,555) 28,618
Comprehensive income $ 1,358,078 $ 268,731
Basic net income (loss) per share:    
Continuing operations $ (0.09) $ (0.08)
Discontinued operations 0.25 0.11
Basic net income (loss) per share 0.16 0.03
Diluted net income (loss) per share:    
Continuing operations (0.09) (0.08)
Discontinued operations 0.25 0.11
Diluted net income (loss) per share $ 0.16 $ 0.03
Weighted Average Basic Shares Outstanding 9,265,590 9,176,093
Weighted Average Dilutive Shares Outstanding 9,445,299 9,176,093
Dividends declared per share $ 0.02 $ 0.02